Anacor Pharmaceuticals, Inc. 4
4 · Anacor Pharmaceuticals, Inc. · Filed Jan 19, 2016
Insider Transaction Report
Form 4
Zane Lee
VP, Clinical Dev & Interim CMO
Transactions
- Sale
Common Stock
2016-01-15$89.57/sh−1,466$131,310→ 27,281 total
Footnotes (1)
- [F1]This sale was effected pursuant to a pre-existing Rule 10b5-1 trading plan adopted by the reporting person.